GILLIS STEVEN
CIK 1229592
Transactions on file
11
Open-market buys
5
Win rate (buys)
0%
3 scored
Avg % since filing (buys)
-20.3%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 7,523,682 | — | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 1,432,224 | $25.78M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | Buy | 789,998 | $14.22M | — | open → |
| 2025-02-03 | 2025-02-03 | MTSR Metsera, Inc. | 10% | C | 16,006,949 | — | — | open → |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | Buy | 1,100,000 | $19.80M | -4.3% | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,681,265 | $0.00 | — | open → | |
| 2026-05-04 | 2026-05-04 | SPTX Seaport Therapeutics, Inc. | C | 2,513,686 | $0.00 | — | open → | |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 8,313,680 | $0.00 | — | open → |
| 2025-11-14 | 2025-11-13 | MTSR Metsera, Inc. | Director10% | Disp. | 18,503,128 | $0.00 | — | open → |
| 2025-10-29 | 2025-10-27 | NMRA Neumora Therapeutics, Inc. | 10% | Buy | 1,915,700 | $5.00M | -38.7% | open → |
| 2025-08-01 | 2025-08-01 | PRME Prime Medicine, Inc. | 10% | Buy | 3,030,300 | $10.00M | -17.9% | open → |
